Bipolar Disorder Market Analysis By Drug Class (Mood stabilizer, Anticonvulsant, Antipsychotic, Antidepressant, Antianxiety), By Mechanism of Action, By Region, And Segment Forecasts, 2018 - 2025

Table of Contents

Chapter 1 Research Methodology
                 1.1 Information Procurement
                 1.2 Information or Data Analysis
                 1.3 Market Formulation & Validation
                 1.4 Region Wise Market Calculation
                     1.4.1 Region wise market: Base estimates
                     1.4.2 Global market: CAGR calculation
Chapter 2 Executive Summary
                 2.1 Market Snapshot
Chapter 3 Bipolar disorder Market Variables, Trends & Scope
                 3.1 Market Segmentation & Scope
                     3.1.1 Market driver analysis
                         3.1.1.1 Increasing prevalence of bipolar disorder
                         3.1.1.2 Increasing government support
                         3.1.1.3 Technological advancements
                     3.1.2 Market restraint analysis
                         3.1.2.1 Side effects associated with bipolar drugs
                         3.1.2.2 Misdiagnosis of bipolar disorder
                 3.2 Penetration & Growth Prospect Mapping
                 3.3 SWOT Analysis, By Factor (political & legal, economic, and technological)
                     3.3.1 Market SWOT Analysis, By Factor (political & legal, economic, and technological)
                 3.4 Industry Analysis - Porter’s
                     3.4.1 Porter’s Five Forces analysis
Chapter 4 Bipolar disorder Drug Class Estimates & Trend Analysis
                 4.1 Bipolar disorder Market: Drug Class Movement Analysis
                 4.2 Mood stabilizer
                     4.2.1 Mood stabilizer market estimates & forecasts, 2014 - 2025 (USD Million)
                 4.3 Anticonvulsants
                     4.3.1 Anticonvulsant market estimates & forecasts, 2014 - 2025 (USD Million)
                 4.4 Antipsychotic drugs
                     4.4.1 Antipsychotic drugs market estimates & forecasts, 2014 - 2025 (USD Million)
                 4.5 Antidepressant drugs
                     4.5.1 Antidepressant drugs market estimates & forecasts, 2014 - 2025 (USD Million)
                 4.6 Antianxiety drugs
                     4.6.1 Antianxiety drugs market estimates & forecasts, 2014 - 2025 (USD Million)
Chapter 5 Bipolar disorder Mechanism of Action Estimates & Trend Analysis
                 5.1 Bipolar disorder Market: Mechanism of Action Movement Analysis
                 5.2 Selective serotonin reuptake inhibitor
                     5.2.1 Selective serotonin reuptake inhibitor market estimates & forecasts, 2014 - 2025 (USD Million)
                 5.3 Serotonin norepinephrine reuptake inhibitor
                     5.3.1 Serotonin norepinephrine reuptake inhibitor market estimates & forecasts, 2014 - 2025 (USD Million)
                 5.4 Tricyclic antidepressants
                     5.4.1 Tricyclic antidepressants market estimates & forecasts, 2014 - 2025 (USD Million)
                 5.5 Monoamine oxidase inhibitor
                     5.5.1 Monoamine oxidase inhibitor market estimates & forecasts, 2014 - 2025 (USD Million)
                 5.6 Benzodiazepines
                     5.6.1 Benzodiazepines market estimates & forecasts, 2014 - 2025 (USD Million)
                 5.7 Benzodiazepines
                     5.7.1 Beta blockers market estimates & forecasts, 2014 - 2025 (USD Million)
                 5.8 Others
                     5.8.1 Others market estimates & forecasts, 2014 - 2025 (USD Million)
Chapter 6 Bipolar disorder Regional Estimates & Trend Analysis, by Drug Class, and Mechanism of Action.
                 6.1 Bipolar disorder Market Share By Region, 2016 & 2025
                 6.2 North America
                     6.2.1 North America bipolar disorder market estimates & forecasts, 2014 - 2025 (USD Million)
                     6.2.2 U.S.
                         6.2.2.1 U.S. bipolar disorder market estimates & forecasts, 2014 - 2025 (USD Million)
                     6.2.3 Canada
                         6.2.3.1 Canada bipolar disorder market estimates & forecasts, 2014 - 2025 (USD Million)
                 6.3 Europe
                     6.3.1 Europe bipolar disorder market estimates & forecasts, 2014 - 2025 (USD Million)
                     6.3.2 UK
                         6.3.2.1 UK bipolar disorder market estimates & forecasts, 2014 - 2025 (USD Million)
                     6.3.3 Germany
                         6.3.3.1 Germany bipolar disorder market estimates & forecasts, 2014 - 2025 (USD Million)
                     6.3.4 France
                         6.3.4.1 France bipolar disorder market estimates & forecasts, 2014 - 2025 (USD Million)
                 6.4 Asia Pacific
                     6.4.1 Asia Pacific bipolar disorder market estimates & forecasts, 2014 - 2025 (USD Million)
                     6.4.2 Japan
                         6.4.2.1 Japan bipolar disorder market estimates & forecasts, 2014 - 2025 (USD Million)
                     6.4.3 China
                         6.4.3.1 China bipolar disorder market estimates & forecasts, 2014 - 2025 (USD Million)
                 6.5 Latin America
                     6.5.1 Latin America bipolar disorder market estimates & forecasts, 2014 - 2025 (USD Million)
                     6.5.2 Brazil
                         6.5.2.1 Brazil bipolar disorder market estimates & forecasts, 2014 - 2025 (USD Million)
                     6.5.3 Mexico
                         6.5.3.1 Mexico bipolar disorder market estimates & forecasts, 2014 - 2025 (USD Million)
                 6.6 MEA
                     6.6.1 MEA bipolar disorder market estimates & forecasts, 2014 - 2025 (USD Million)
                     6.6.2 South Africa
                         6.6.2.1 South Africa bipolar disorder market estimates & forecasts, 2014 - 2025 (USD Million)
Chapter 7 Competitive Landscape
                 7.1 Strategy framework
                 7.2 Company Profiles
                     7.2.1 GlaxoSmithKline
                         7.2.1.1 Company overview
                         7.2.1.2 Financial performance
                         7.2.1.3 Product benchmarking
                         7.2.1.4 Strategic initiatives
                     7.2.2 Pfizer Inc.
                         7.2.2.1 Company overview
                         7.2.2.2 Financial performance
                         7.2.2.3 Product benchmarking
                         7.2.2.4 Strategic initiatives
                     7.2.3 Janssen Pharmaceuticals
                         7.2.3.1 Company overview
                         7.2.3.2 Financial performance
                         7.2.3.3 Product benchmarking
                         7.2.3.4 Strategic initiatives
                     7.2.4 Eli Lily
                         7.2.4.1 Company overview
                         7.2.4.2 Financial performance
                         7.2.4.3 Product benchmarking
                         7.2.4.4 Strategic initiatives
                     7.2.5 Allergan Plc.
                         7.2.5.1 Company overview
                         7.2.5.2 Financial performance
                         7.2.5.3 Product benchmarking
                         7.2.5.4 Strategic initiatives
                     7.2.6 Norvartis
                         7.2.6.1 Company overview
                         7.2.6.2 Financial performance
                         7.2.6.3 Product benchmarking
                         7.2.6.4 Strategic initiatives
                     7.2.7 AbbVie Inc.
                         7.2.7.1 Company overview
                         7.2.7.2 Financial performance
                         7.2.7.3 Product benchmarking
                         7.2.7.4 Strategic initiatives
                     7.2.8 Otsuka Holdings Co.Ltd
                         7.2.8.1 Company overview
                         7.2.8.2 Financial performance
                         7.2.8.3 Product benchmarking
                         7.2.8.4 Strategic initiatives
                     7.2.9 AstraZeneca
                         7.2.9.1 Company overview
                         7.2.9.2 Financial performance
                         7.2.9.3 Product benchmarking
                         7.2.9.4 Strategic initiatives

List of Tables

TABLE 1 North America bipolar disorder market estimates and forecast by drug class, 2014 - 2025
TABLE 2 North America bipolar disorder market estimates and forecast by mechanism of action, 2014 - 2025 (USD Million)
TABLE 3 U.S. bipolar disorder market estimates and forecast by drug class, 2014 - 2025
TABLE 4 U.S. bipolar disorder market estimates and forecast by mechanism of action (USD Million)
TABLE 5 Canada bipolar disorder market estimates and forecast by drug class, 2014 - 2025 (USD Million)
TABLE 6 Canada bipolar disorder market estimates and forecast by mechanism of action (USD Million)
TABLE 7 Europe bipolar disorder market estimates and forecast by drug class, 2014 - 2025
TABLE 8 Europe bipolar disorder market estimates and forecast by mechanism of action, 2014 - 2025
TABLE 9 U.K bipolar disorder market estimates and forecast by drug class, 2014 - 2025
TABLE 10 U.K bipolar disorder market estimates and forecast by mechanism of action, 2014 - 2025 (USD Million)
TABLE 11 Germany bipolar disorder vitamin market estimates and forecast by drug class, 2014 - 2025 (USD Million)
TABLE 12 Germany bipolar disorder antioxidants market estimates and forecast by mechanism of action, 2014 - 2025
TABLE 13 Asia Pacific bipolar disorder market estimates and forecast by drug class, 2014 - 2025
TABLE 14 Asia Pacific bipolar disorder market estimates and forecast by mechanism of action, 2014 - 2025 (USD Million)
TABLE 15 China bipolar disorder market estimates and forecast by drug class, 2014 - 2025
TABLE 16 China bipolar disorder market estimates and forecast by mechanism of action (USD Million)
TABLE 17 Japan bipolar disorder market estimates and forecast by drug class, 2014 - 2025
TABLE 18 Japan bipolar disorder market estimates and forecast by mechanism of action (USD Million)
TABLE 19 Latin America other bipolar disorder market estimates and forecast by drug classs, 2014 - 2025 (USD Million)
TABLE 20 Latin America bipolar disorder market estimates and forecast by mechanism of action, 2014 - 2025
TABLE 21 Brazil bipolar disorder market estimates and forecast by drug class, 2014 - 2025
TABLE 22 Brazil bipolar disorder market estimates and forecast by mechanism of action (USD Million)
TABLE 23 Mexico bipolar disorder market estimates and forecast by drug class, 2014 - 2025 (USD Million)
TABLE 24 Mexico bipolar disorder market estimates and forecast by mechanism of action, 2014 - 2025
TABLE 25 Middle East Asia bipolar disorder market estimates and forecast by drug class, 2014 - 2025
TABLE 26 Middle East Asia bipolar disorder market estimates and forecast by mechanism of action, 2014 - 2025 (USD Million)
TABLE 27 South Africa bipolar disorder market estimates and forecast by drug class, 2014 - 2025
TABLE 28 South Africa bipolar disorder market estimates and forecast by mechanism of action (USD Million)
TABLE 29 Saudi Arabia bipolar disorder market estimates and forecast by drug class, 2014 - 2025
TABLE 30 Saudi Arabia bipolar disorder market estimates and forecast by mechanism of action (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary, 2016 (USD Million)
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraint relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping
FIG. 13 SWOT Analysis, By Factor (political & legal, economic and social)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Bipolar disorder market drug class outlook key takeaways
FIG. 16 Bipolar disorder market: drug class movement analysis
FIG. 17 Global mood stabilizer market, 2014 - 2025 (USD Million)
FIG. 18 Global anticonvulsant market, 2014 - 2025 (USD Million)
FIG. 19 Global antipsychotic drug market, 2014 - 2025 (USD Million)
FIG. 20 Global antidepressant drug market, 2014 - 2025 (USD Million)
FIG. 21 Global antianxiety drugs market, 2014 - 2025 (USD Million)
FIG. 22 Bipolar disorder market mechanism of action outlook key takeaways
FIG. 23 Bipolar disorder market: mechanism of action movement analysis
FIG. 24 Global selective serotonin reuptake inhibitor market, 2014 - 2025 (USD Million)
FIG. 25 Global serotonin norepinephrine reuptake inhibitor market, 2014 - 2025 (USD Million)
FIG. 26 Global tricyclic antidepressants market, 2014 - 2025 (USD Million)
FIG. 27 Global monoamine oxidase inhibitors market, 2014 - 2025 (USD Million)
FIG. 28 Global benzodiazephines market, 2014 - 2025 (USD Million)
FIG. 29 Global beta blockers equipment market, 2014 - 2025 (USD Million)
FIG. 30 Global others equipment market, 2014 - 2025 (USD Million)
FIG. 31 Regional market place: Key takeaways
FIG. 32 Regional outlook, 2016 & 2025
FIG. 33 North America bipolar disorder market, 2014 - 2025 (USD Million)
FIG. 34 U.S. bipolar disorder market, 2014 - 2025 (USD Million)
FIG. 35 Canada bipolar disorder market, 2014 - 2025 (USD Million)
FIG. 36 Europe bipolar disorder market, 2013 - 2024 (USD Million)
FIG. 37 UK bipolar disorder market, 2013 - 2024 (USD Million)
FIG. 38 Germany bipolar disorder market, 2014 - 2025 (USD Million)
FIG. 39 Asia Pacific bipolar disorder market, 2014 - 2025 (USD Million)
FIG. 40 Japan bipolar disorder market, 2014 - 2025 (USD Million)
FIG. 41 China bipolar disorder market, 2014 - 2025 (USD Million)
FIG. 42 Latin America bipolar disorder market, 2014 - 2025 (USD Million)
FIG. 43 Brazil bipolar disorder market, 2014 - 2025 (USD Million)
FIG. 44 Mexico bipolar disorder market, 2014 - 2025 (USD Million)
FIG. 45 MEA bipolar disorder market, 2014 - 2025 (USD Million)
FIG. 46 South Africa bipolar disorder market, 2014 - 2025 (USD Million)
FIG. 47 Saudi Arabia bipolar disorder market, 2014 - 2025 (USD Million)
FIG. 48 Strategy framework